(E)-N-Methyl-3-phenylprop-2-en-1-amine

Catalog No. :
ACIKLV259
CAS No. :
83554-67-0
Molecular Formula :
C10H13N
Molecular Weight :
147.22

IUPAC Name:(E)-N-methyl-3-phenylprop-2-en-1-amine

(E)-N-Methyl-3-phenylprop-2-en-1-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$64.00Login to see priceIn stockInquiry
1g95%$163.00Login to see priceIn stockIn stock
5g95%$569.00Login to see priceIn stockIn stock
10g95%$1021.00Login to see priceIn stockIn stock
25g95%$2476.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(E)-N-Methyl-3-phenylprop-2-en-1-amine
IUPAC Name(E)-N-methyl-3-phenylprop-2-en-1-amine
Molecular FormulaC10H13N
Molecular Weight147.22
SMILESCNC/C=C/C1=CC=CC=C1
InChI KeyRHPMSSCVPPONDM-VMPITWQZSA-N
SynonymCHEMBRDG-BB 9070687;N-METHYL-3-PHENYL-2-PROPEN-1-AMINE;N-methyl-3-phenyl-2-propen-1-amine(SALTDATA: FREE);Fluoxetine Impurity 6(EP-F);Fluoxetine EP Impurity F;Atomoxetine Impurity 17;2-Propen-1-amine, N-methyl-3-phenyl-, (2E)-;Atomoxetine Impurity 36
CAS No.83554-67-0
PubChem CID6387604

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H315-H318-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340+P312-P305+P351+P338+P310-P332+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACIKLV259 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIKLV259 route product structure diagram
    ACIKLV25983554-67-0 In Stock
Inquiry

2. ACIKLV259 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIKLV259 route product structure diagram
    ACIKLV25983554-67-0 In Stock
Inquiry

Comments (0)